tradingkey.logo

Cero Therapeutics Announces Critical Patent Application Allowances From The U.S. Patent Office

ReutersApr 10, 2025 2:18 PM

- CERo Therapeutics Holdings Inc CERO.O:

  • CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES CRITICAL PATENT APPLICATION ALLOWANCES FROM THE U.S. PATENT OFFICE COVERING COMPANY’S LEAD COMPOUND CER-1236

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI